Ematoncologia

Il volume propone un viaggio nel mondo oncoematologico, un dialogo tra professionalità diverse che accoglie la voce dei pazien

Bone Marrow Pathology has been extensively revised to reflect the significant advances which have occurred in the application of cytogenetics and in particular, molecular genetics in the diagnosis, classification and understanding of haematological disorders. This comprehensive book not only provides information on all common disease entities, but also covers rare disorders in which bone marrow examination is useful. It is designed as a practical resource with "problems and pitfalls" highlighted throughout to aid laboratory diagnosis.

For those preparing for certification or recertification in hematology or oncology, Hoffman and Abeloff's Hematology-Oncology Review is a single-volume source of authoritative, up-to-date exam preparation. This unique question and answer review helps you succeed on today's board exams with more than 1,000 board-style questions, answers, and rationales; comprehensive coverage of essential exam topics, and online practice tests.Includes 1,000+ board-style questions with answers and rationales explaining both correct and incorrect answers. Features three online practice tests per specialty that follow the ABIM exams blueprint, ensuring that complex content is delivered in easily digestible segments for more efficient review. Covers a broad range of topics compiled by experts in hematology and oncology, including cancer biology and genomics, immunotherapy, hematologic malignancies, solid tumor malignancies, non-malignant hematology, and supportive care. Uniquely designed as both a standalone review and a study companion to Abeloff's Clinical Oncology and Hematology: Basic Principles and Practice. Expert ConsultT eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, and references from the book on a variety of devices.

Concise, portable, and user-friendly, The Washington Manual Hematology and Oncology Subspecialty Consult, 4th Edition, provides quick access to the essential information needed to evaluate a patient on a subspecialty consult service. This edition offers state-of-the-art content, including coverage of new anti-cancer drugs and new biomarkers and therapeutic targets. Ideal for fellows, residents, and medical students rotating on hematology and oncology subspecialty services, the manual is also useful as a first-line resource for internists and other primary care providers. Key Features:*Thoroughly revised to include new standards in the treatment of malignancies and hematologic disorders, mechanisms of action of new therapeutic agents, and the current use of molecular prognostic factors.* A new chapter on immunotherapy reviews approved and potentially approved new therapies that help you improve clinical outcomes for your patients.* A reorganized, consistent format throughout ensures that you can find what you need quickly and easily.*Comprehensive coverage addresses all areas of hematology and oncology.* Symptoms, signs, and problems encountered in daily practice are presented in a quick-reference bulleted format.*Updated references are provided for readers who would like additional information on a particular topic.* Written by fellows and junior faculty from the Washington University School of Medicine in St. Louis.Now with the print edition, enjoy the bundled interactive eBook edition, which can be downloaded to your tablet and smartphone or accessed online and includes features like:*Complete content with enhanced navigation*Powerful search tools and smart navigation cross-links that pull results from content in the book, your notes, and even the web*Cross-linked pages, references, and more for easy navigation*Highlighting tool for easier reference of key content throughout the text* Ability to take and share notes with friends and colleagues*Quick reference tabbing to save your favorite content for future use

Hematology and Oncology - as only Harrison's can cover it. Featuring a superb compilation of chapters on hematology and oncology that appear in "Harrison's Principles of Internal Medicine, Eighteenth Edition", this concise, full-color clinical companion delivers the latest knowledge in the field backed by the scientific rigor and authority that have defined Harrison's. You will find content from renowned editors and contributors in a carry-anywhere presentation that is ideal for the classroom, clinic, ward, or exam/certification preparation. It features: organized into twelve sections: The Cellular Basis of Hematopoiesis; Cardinal Manifestations of Hematologic Diseases; Anemias, Myeloproliferative Disorders; Hematologic Malignancies; Disorders of Hemostasis; Biology of Cancer; Principles of Cancer Prevention and Treatment; Neoplastic Disorders; Endocrine Neoplasia; Remote Effects of Cancer; and Oncologic Emergencies and Late Effects Complications; each chapter contents relevant information on the genetics, cell biology, pathophysiology, and treatment of specific disease entities; chapters on hematopoiesis, cancer cell biology, and cancer prevention reflect the rapidly growing body of knowledge in these areas; integration of pathophysiology with clinical management; 153 high-yield questions and answers drawn from "Harrison's Principles of Internal Medicine Self-Assessment and Board Review, 18e". Content updates and new developments since the publication of "Harrison's Principles of Internal Medicine, 18e"; 55 chapters written by physicians who are recognized experts in the field of hematology and oncology; and helpful appendix of laboratory values of clinical importance.

Flow Cytometry of Hematological Malignancies contains an array of graphical outputs produced by the technique in the study of the most (and the least) common diseases. The images included allow you to compare your own results with a third party reference pattern. There is a detailed description of the main leukocyte antigens, together with a description of their distribution amongst normal and abnormal blood cells. The book also provides a comprehensive description of the phenotype of every neoplastic blood disease recorded in the WHO classification system, including all the instructions needed to recognise and classify even the least common entity. Designed to be practical, the book is perfect for quick consultation and is divided into two main sections. Section I deals with the direct object of immunophenotyping, and Section II deals with the ultimate target of the analysis. More than 50 antigens are covered and every antigen is dealt with in three main parts: general features, cytometric features and practical hints. This authoritative and state-of-the-art reference will be invaluable for clinicians directly involved in the diagnosis and analysis of hematological diseases, including hematologists, hematopathologists, oncologists, pathologists and technicians working in diagnostic laboratories.

This issue compiled by Dr. Nancy Berliner focuses on such topics as: A History of Bone Marrow Transplantation, Hematopoietic Stem Cell Transplantation for Severe Combined Immune Deficiency Or What the Children have Taught Us; HLA-haploidentical Donor Transplantation in Severe Combined Immunodeficiency; Haploidentical Bone Marrow Transplantation in Primary Immune Deficiency - Stem Cell Selection and Manipulation; Suffering from Severe Combined Immunodeficiency; Herpes Viruses in Transplant Recipients: HSV,VZV, Human Herpes Viruses, and EBV; and, Immunotherapy and Vaccination After Transplant - The Present, the Future.

Progress in the treatment of cancer over the past two decades has been rapid with many new and novel therapeutic modalities arriving at an unprecedented pace. Overall cancer mortality rates have actually begun to fall in parallel with progress in the diagnosis and treatment of malignant disease. Despite our advances in the understanding of the biology and molecular genetics of cancer, as well as the availability of an increasing array of effective therapies, cancer treatment today and for the foreseeable future will include the traditional modalities of surgery, radiation therapy and chemotherapy. Myelosuppressive agents with their potential hematopoietic toxicities remain the mainstay of systemic treatment for both metastatic and early stage cancer. The complications of cancer chemotherapy have serious impact on a patient's well being and overall quality of life. Fortunately, advances in cancer treatment have been accompanied by equally impressive progress in the availability of a wide array of supportive care modalities which have greatly enhanced the ability of oncologists to minimize the impact of cancer and its treatment on patient quality of life as well improve delivery of potentially curative cancer treatment. Despite the increasing complexity of modern cancer treatment, it is the obligation of the oncologist as well as the entire cancer care team to be certain that cancer patients receive the optimal supportive care available for their disease and its treatment. Among the most serious and potentially life threatening toxicities of cancer treatment are the hematologic toxicities accompanying myelosuppression including anemia and associated asthenia and fatigue, neutropenia and fever associated with infection in the immunocompromised patient and thrombocytopenia and accompanying risk of bleeding. Special supportive care needs arise in the very elderly care patient that may tax the ability of even the most skilled clinician. Despite the considerable progress that has been made with more effective and safer treatment strategies, myelosuppressive chemotherapy will remain the mainstay of systemic treatment for cancer for the foreseeable future. While considerable progress has occurred, better methods and broader application of supportive care measures are needed to reduce the symptomatic effects of cancer and the associated toxicities associated with cancer treatment. No area of cancer supportive care better illustrates the progress that has resulted from advances in our understanding of cellular and molecular biology, genetic engineering and the development of more effective yet often more toxic cancer treatments than that of the hematopoietic growth factors. This volume will review and integrate the major advances in our understanding of the underlying molecular biology and pharmacology of these agents along with the results of well designed and executed randomized controlled trials of the erythroid stimulating agents, the myeloid growth factors and the new thrombopoietic agents each addressing a major threat associated with bone marrow suppression accompanying cancer treatment. The current clinical utilization of these agents is based on numerous randomized controlled trials and meta-analyses along with evidence-based clinical practice guidelines developed by professional societies guiding their appropriate and cost-effective use in clinical care.

Thoroughly updated for its second edition, "Non-Hodgkin Lymphomas" is the definitive textbook on the biology, diagnosis, staging, and treatment of all forms of non-Hodgkin lymphomas. With backgrounds in medical and radiation oncology, molecular biology, and pathology, the editors and contributors provide an international, multidisciplinary approach to the topic. This edition is the first text using the new World Health Organization classification of non-Hodgkin lymphomas. The book offers complete coverage of the most current techniques for diagnosis, staging, and treatment, the approach to specific types of lymphoma, and special problems common to the management of patients with these disorders. A companion Website includes the fully searchable text and downloadable images.

This book will assist pathologists, hematologists, and oncologists in interpreting peripheral blood and bone marrow specimens quickly, easily, and accurately. Featuring more than 400 full-color illustrations, the book is a very complete survey of bone marrow diseases, including rare entities, and provides up-to-date information on constitutional and acquired disorders in both adults and children. This edition includes the latest information on hematologic and associated diseases, including many new disease descriptions, recent genetic and immunologic findings, and the current World Health Organization classification of hematolymphoid disorders. A companion Website will offer the fully searchable text and an image bank.

This highly popular book in the proven question-and-answer format of the Secrets Series[registered] is better than ever in this completely updated new edition. The major sections are General Concepts, General Hematology, Malignant Hematology, Care of the Cancer Patient, and Solid Tumors. Concise, and yet comprehensive with over 90 chapters written by experts in the field, this book presents all the need-to-know key information and provides the insights, pearls, and "secrets" that are the hallmark of the series.

Innovative Leukemia and Lymphoma Therapy provides a complete and up-to-date overview of the exciting new treatment modalities in leukemia and lymphoma that are being introduced in the clinic today. Written by international experts in the field, this volume examines clinical studies on topics such as: tyrosine kinase inhibitors, histon deacetylase inhibitors, and farnesyl transferase inhibitors radioimmunotherapy, gene-directed therapy, and immunotherapy by vaccination monoclonal antibodies anti-angiogenesis approaches Within each chapter, this well-illustrated, comprehensive source provides a summary of the rationale for treatment, the pathways that are involved, and the translational research to students, scientists, and clinicians. In addition, this book focuses on the concerns of conventional but novel anticancer agents, modulation of classical multidrug resistance, and modulators of single agent drug resistance.

Now in its Fourth Edition, this comprehensive, practical, and thoroughly illustrated reference offers valuable guidance in the diagnostic interpretation of lymph node biopsies. It provides encyclopedic coverage of all the various nonmalignant lesions, lymphomas, other neoplasms, and metastatic tumors in lymph nodes. The discussion of each pathologic entity includes definition, clinical syndrome, histopathology, and differential diagnosis. This edition has more than 700 illustrations, including over 600 in full color. Dr. Ioachim is joined by a new co-editor, L. Jeffrey Medeiros, MD, from the University of Texas MD Anderson Cancer Center. All chapters have been extensively revised and a new chapter on genetics has been added. A companion Website will offer the fully searchable online text and an image bank.

Prepared by residents and fellows and reviewed by clinical faculty at the Washington University School of Medicine, this handbook is a practical quick-reference guide to the diagnosis and treatment of hematologic disorders and adult malignancies. It covers both inpatient and outpatient management approaches with the same front-lines practicality as the world-famous Washington Manual(R) of Medical Therapeutics. This thoroughly updated Second Edition includes new standards in the treatment of malignancies, mechanisms of action of new therapeutic agents, and the current use of molecular prognostic factors. Key points about diagnosis and management of disorders are bulleted for easy reference. This edition also includes illustrations. The Washington Manual(R) is a registered mark belonging to Washington University in St. Louis to which international legal protection applies. The mark is used in this publication by LWW under license from Washington University.